daunorubicin has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helenius, T; Perkkiö, M; Riikonen, P; Tikanoja, T | 1 |
| Ikeno, A; Ishikawa, T; Iuchi, K; Matsuda, T; Nakamura, S; Ohtake, S; Okumura, H; Takamatsu, H; Takeshima, M; Usuda, K; Yoshida, T | 1 |
2 other study(ies) available for daunorubicin and atrial natriuretic factor
| Article | Year |
|---|---|
Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up in children with cancer.
Topics: Adolescent; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Cardiovascular System; Child; Child, Preschool; Daunorubicin; Doxorubicin; Echocardiography; Electrocardiography; Female; Humans; Infant; Male; Predictive Value of Tests | 1998 |
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Biomarkers; Cardiac Output, Low; Daunorubicin; Female; Heart Diseases; Heart Failure; Heart Function Tests; Humans; Leukemia; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric | 2000 |